drugset / Trial / NCT02235428

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

NCT02235428

Phase 4 Terminated 3 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine whether addition of ipratropium bromide to salbutamol nebulisations produces significantly greater bronchodilation in young children presenting to an emergency department with an acute attack of asthma

Timeline

Start
1998-09
Primary completion
1998-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule Other
Subject Salbutamol Unknown Other

Indications